↓ Skip to main content

Should persons with acute myeloid leukemia (AML) in 1st histological complete remission who are measurable residual disease (MRD) test positive receive an allotransplant?

Overview of attention for article published in Leukemia, March 2020
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (51st percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
5 X users

Citations

dimensions_citation
14 Dimensions

Readers on

mendeley
28 Mendeley
Title
Should persons with acute myeloid leukemia (AML) in 1st histological complete remission who are measurable residual disease (MRD) test positive receive an allotransplant?
Published in
Leukemia, March 2020
DOI 10.1038/s41375-020-0780-6
Pubmed ID
Authors

Adriano Venditti, Robert Peter Gale, Francesco Buccisano, Gert Ossenkoppele

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 28 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 28 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 9 32%
Other 2 7%
Student > Bachelor 2 7%
Professor > Associate Professor 2 7%
Student > Doctoral Student 1 4%
Other 5 18%
Unknown 7 25%
Readers by discipline Count As %
Medicine and Dentistry 14 50%
Biochemistry, Genetics and Molecular Biology 2 7%
Unspecified 1 4%
Mathematics 1 4%
Unknown 10 36%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 September 2020.
All research outputs
#14,182,801
of 24,717,821 outputs
Outputs from Leukemia
#3,890
of 5,332 outputs
Outputs of similar age
#173,678
of 365,900 outputs
Outputs of similar age from Leukemia
#56
of 90 outputs
Altmetric has tracked 24,717,821 research outputs across all sources so far. This one is in the 41st percentile – i.e., 41% of other outputs scored the same or lower than it.
So far Altmetric has tracked 5,332 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.4. This one is in the 26th percentile – i.e., 26% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 365,900 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 51% of its contemporaries.
We're also able to compare this research output to 90 others from the same source and published within six weeks on either side of this one. This one is in the 34th percentile – i.e., 34% of its contemporaries scored the same or lower than it.